There is an urgent need for structurally novel antibiotic compounds, with unique mechanisms of action. Deep learning approaches have increased discovery rates, but efforts have largely been applied to ...
Vancouver firm's AI platform will generate chemical compounds based on Merck’s therapeutic targets. A Vancouver startup using artificial intelligence (AI) to discover new drugs has struck a deal with ...
Variational AI Inc., a Vancouver startup that uses generative artificial intelligence to discover therapeutic drugs, has signed a two-year development deal with Merck & Co. Inc. MRK-N that could be ...
Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...
Abstract: The identification of encrypted network traffic presents a pivotal challenge in detecting unknown malicious traffic. Unlike closed-set identification, which primarily classifies known ...
VANCOUVER, British Columbia–(BUSINESS WIRE)–#AIDD—Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the United States ...
Huzhou Key Laboratory of Intelligent Sensing and Optimal Control for Industrial Systems, School of Engineering, Huzhou University, Huzhou 313000, PR China Zhejiang Key Laboratory of Industrial Solid ...
School of Computer Science and Artificial Intelligence, Wuhan Textile University, Wuhan, Hubei 430200, China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback